- Latest week
- 17 Jul 2026
- Close
- 2.902000
- Fair value
- 2.373218
- Next-week expectancy
- Negative 41.45%
ORY Chart Pack
Oryzon Genomics S.A.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, ORY rose 4.24%, moving from 2.78 to 2.90. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -15.26 and has improved across the 12-week window. Market Dynamics is 0.55 on the latest week. Next-week expectancy is negative at 41.45% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 2.90
- 12-Week Change
- 4.24%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 41.45%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -15.26
- Market Dynamics
- 0.55
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 2.90
- 12-Week Change
- 4.24%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 41.45%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -15.26
- Market Dynamics
- 0.55
Over the latest 12 completed weeks ending 2026-07-17, ORY rose 4.24%, moving from 2.78 to 2.90. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -15.26 and has improved across the 12-week window. Market Dynamics is 0.55 on the latest week. Next-week expectancy is negative at 41.45% based on similar historical setup states.
Industry Peers
Spain equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| BST Biotechnology Assets, S.A. | MCE | 17 Jul 2026 | 0.21 | 0.22 | 0.19 | 0.21 | 1.94% |
| VYT Vytrus Biotech, S.A. | MCE | 17 Jul 2026 | 17.30 | 18.00 | 16.25 | 17.00 | -1.73% |
| PHM Pharma Mar, S.A. | MCE | 17 Jul 2026 | 79.40 | 79.50 | 73.85 | 75.60 | -4.79% |
| ATRY Atrys Health, S.A. | MCE | 17 Jul 2026 | 2.50 | 2.50 | 2.31 | 2.37 | -5.20% |